GRI Bio shareholders authorize reverse stock split at ratio of 1:2 to 1:23

GRI Bio, Inc.

Special meeting held Feb 11, 2025; quorum of 4,640,469 shares (51.94%) present.
Reverse split proposal approved: 3,151,775 for, 1,484,078 against, 4,616 abstain.
Board may set exact ratio within 1:2 to 1:23 range and can abandon split entirely.
Adjournment proposal also approved: 3,237,240 for, 1,390,423 against, 12,806 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.